نتایج جستجو برای: hbsag epitopes mutations

تعداد نتایج: 201746  

Journal: :iranian biomedical journal 0
نادر شاهرخی nader shahrokhi سعید بوذری saeid bouzari انیس جعفری anis jafari

we developed an immunogen to stimulate multivalent immunity against hepatitis b surface antigen (hbsag) and hepatitis b core antigens (hbcag). immune responses specific for both hbsag and hbcag play an important role in controlling the infection. hbsag-specific antibodies mediate elimination of virions at an early stage of infection and prevent the spread of virus. the immunogen was constructed...

2011
Nader Shahrokhi Saeid Bouzari Anis Jafari

We developed an immunogen to stimulate multivalent immunity against hepatitis B surface antigen (HBsAg) and hepatitis B core antigens (HBcAg). Immune responses specific for both HBsAg and HBcAg play an important role in controlling the infection. HBsAg-specific antibodies mediate elimination of virions at an early stage of infection and prevent the spread of virus. The immunogen was constructed...

Journal: :iranian journal of public health 0
m norouzi sa ghorashi f abedi a nejatizadeh b ataei r malekzadeh

background: hepatitis b virus (hbv) gene and protein variations are frequently been seen in chronic patients. the aims of study were to determine the genotypes as well as the patterns of variations distribution in chronically-infected patients from the central part of iran. methods: the surface gene was amplified, sequenced and subsequently aligned using international and national iranian datab...

Journal: :Journal of immunology 2002
Petra Riedl Shereen El-Kholy Jörg Reimann Reinhold Schirmbeck

The immunodominant, conformational "a" determinant of hepatitis B surface Ag (HBsAg) elicits Ab responses. We selectively expressed the Ab-binding, glycosylated, native a determinant (residue 120-147) of HBsAg in a fusion protein containing C-terminally the HBsAg fragment SII (residue 80-180) fused to a SV40 T-Ag-derived hsp73-binding 77 aa (T(77)) or non-hsp-binding 60 aa (T(60)) N terminus. A...

Journal: :Proceedings of the National Academy of Sciences of the United States of America 1995
M Rajadhyaksha Y Thanavala

A pentadecapeptide (2F10 peptide) is capable of mimicking the group-specific "a" determinant of human hepatitis B surface antigen (HBsAg) at both the B- and the T-cell level. This peptide represents a sequence on the heavy-chain hypervariable region of a monoclonal "internal image" anti-idiotype (anti-id 2F10) that has partial sequence homology to the "a" determinant epitope of HBsAg. To identi...

2010
Mehdi Norouzi Seyed Ali Ghorashi Behrooz Ataei Majid Yaran Reza Malekzadeh Seyed Moayyed Alavian Mohammad Ali Judaki Shiva Ghamari Alireza Namazi Ramin Rahimnia Mohammad Jazayeri

Objective(s) The aim of this study was to characterize the hepatitis B virus surface protein genotypes and sequence variations among hepatitis B virus surface antigen (HBsAg) positive chronic patients in Hormozgan province, south of Iran. Materials and Methods A total of 8 patients enrolled in this study. The surface gene was amplified and directly sequenced. Genotypes and nucleotide/amino acid...

Journal: :Antiviral research 2012
Valentina Svicher Valeria Cento Martina Bernassola Maria Neumann-Fraune Formijn Van Hemert Mengjie Chen Romina Salpini Chang Liu Roberta Longo Michela Visca Sara Romano Valeria Micheli Ada Bertoli Caterina Gori Francesca Ceccherini-Silberstein Cesare Sarrecchia Massimo Andreoni Mario Angelico Antonella Ursitti Alberto Spanò Jing Maria Zhang Jens Verheyen Giuseppina Cappiello Carlo Federico Perno

Occult HBV infection (OBI) is a threat for the safety of blood-supply, and has been associated with the onset of HBV-related hepatocellular carcinoma and lymphomagenesis. Nevertheless, genetic markers in HBsAg (particularly in D-genotype, the most common in Europe) significantly associated with OBI in vivo are missing. Thus, the goal of this study is to define: (i) prevalence and clinical profi...

2014
Giovanni Galati Antonio De Vincentis Umberto Vespasiani-Gentilucci Paolo Gallo Donatella Vincenti Maria Carmela Solmone Chiara Dell’Unto Antonio Picardi

BACKGROUND Some reports have documented the coexistence of Hepatitis B surfage Antigen (HBsAg) and anti-HBsAg antibodies (HBsAb) in patients with chronic hepatitis B (CHB), often in the absence of amino acid substitutions in the HBsAg sequences of the Hepatitis B Virus (HBV) genome able to explain an immunological escape variant.HBV genome has a very compact coding organization, with four parti...

Journal: :Antiviral therapy 2014
Mariacarmela Solmone Emanuela Giombini Donatella Vincenti Gabriella Rozera Angela Testa Alessandra Moscetti Manuela Catalano Isabella Abbate Maria R Capobianchi Stefano Menzo

BACKGROUND Entecavir is the drug of choice as first-line treatment for treatment-naive HBV patients. As a result of the high genetic barrier to resistance, treatment failure remains rare, but occurs within 3 years of initiation, suggesting that viral genetic characteristics may provide a fast lane to resistance. One of the main concerns is the long time to viral suppression observed in some (ev...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید